Alexander Eggermont
MD, PhD
Professor of Oncology
👥Biography 个人简介
Alexander Eggermont is a pioneer in melanoma adjuvant therapy who led the EORTC 18071 and KEYNOTE-054 trials establishing ipilimumab and pembrolizumab as adjuvant standards of care. His decades of work transformed post-surgical melanoma management from interferon to modern checkpoint immunotherapy. He has been one of the most impactful figures in melanoma treatment history.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Alexander Eggermont 的研究动态
Follow Alexander Eggermont's research updates
留下邮箱，当我们发布与 Alexander Eggermont（Princess Maxima Center / Utrecht University）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment